A randomized crossover study comparing different tacrolimus formulations to reduce intrapatient variability in tacrolimus exposure in kidney transplant recipients

by Kim L. W. Bunthof, Linda Al‐Hassany, Gizal Nakshbandi, Dennis A. Hesselink, Ron H. N. vanSchaik, Marc A. G. J. ten Dam, Marije C. Baas, Luuk B. Hilbrands, Teun vanGelder
Published 2022-04-01

No Effect of Dose Adjustment to the CYP2D6 Genotype in Patients With Severe Mental Illness

by Anne B. Koopmans, Anne B. Koopmans, David J. Vinkers, Igmar T. Poulina, Petra J. A. Gelan, Ron H. N. van Schaik, Hans W. Hoek, Hans W. Hoek, Hans W. Hoek, Peter N. van Harten, Peter N. van Harten
Published 2018-08-01

Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment

by Daan P. Hurkmans, Jeroen G. H. P. Verhoeven, Kitty de Leur, Karin Boer, Arjen Joosse, Carla C. Baan, Jan H. von der Thüsen, Ron H. N. van Schaik, Ron H. J. Mathijssen, Astrid A. M. van der Veldt, Dennis A. Hesselink
Published 2019-07-01

Influence of Receptor Polymorphisms on the Response to α-Adrenergic Receptor Blockers in Pheochromocytoma Patients

by Annika M. A. Berends, Mathieu S. Bolhuis, Ilja M. Nolte, Edward Buitenwerf, Thera P. Links, Henri J. L. M. Timmers, Richard A. Feelders, Elisabeth M. W. Eekhoff, Eleonora P. M. Corssmit, Peter H. Bisschop, Harm R. Haak, Ron H. N. van Schaik, Samira el Bouazzaoui, Bob Wilffert, Michiel N. Kerstens
Published 2022-04-01